The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

December 2019

Volume 15 Number 11

In this issue the NOTION TRIAL looks at the cost-effectiveness of TAVI in patients at lower surgical risk; the final results of the REDUCE trial examining the optimal duration of DAPT in ACS patients treated with DES; a look at the impact of FFR in guiding CABG – the GRAFFITI trial; BIOFLOW-IV, studying the Orsiro sirolimus-eluting stent; and a study of multivessel PCIs in patients with acute myocardial infarction (AMI) and severe renal dysfunction.

Highlights from this issue

Coronary
FFR-guided versus angio-guided CABG
FFR-guided versus angio-guided CABG
Gabor Toth
Toth G, De Bruyne B, Kala P, Ribichini F, Casselman F, Ramos R, Piroth Z, Fournier S, Piccoli A, Van Mieghem C, Penicka M, Mates M, Nemec P, Van Praet F, Stockman B, Degriek I, Barbato E
December 6, 2019
DOI: 10.4244/EIJ-D-19-00463

Perspectives

Coronary interventions